BTW
XRAY icon

Boston Trust Walden’s Dentsply Sirona XRAY Stock Holding History

Boston Trust Walden’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,650
Closed -$288K – 392
2024
Q3 		$288K Sell
10,650
-940
-8% -$24K ﹤0.01% 348
2024
Q2 		$289K Sell
11,590
-7,450
-39% -$214K ﹤0.01% 348
2024
Q1 		$632K Sell
19,040
-5,740
-23% -$196K ﹤0.01% 306
2023
Q4 		$882K Sell
24,780
-1,917
-7% -$60.8K 0.01% 283
2023
Q3 		$912K Sell
26,697
-3,610
-12% -$137K 0.01% 278
2023
Q2 		$1.21M Sell
30,307
-1,000
-3% -$39.8K 0.01% 268
2023
Q1 		$1.23M Sell
31,307
-11,708
-27% -$430K 0.01% 265
2022
Q4 		$1.37M Sell
43,015
-51,190
-54% -$1.54M 0.01% 263
2022
Q3 		$2.67M Sell
94,205
-37,663
-29% -$1.29M 0.03% 241
2022
Q2 		$4.71M Sell
131,868
-4,320
-3% -$175K 0.04% 232
2022
Q1 		$6.7M Sell
136,188
-17,750
-12% -$938K 0.06% 224
2021
Q4 		$8.59M Sell
153,938
-1,730
-1% -$95.1K 0.07% 218
2021
Q3 		$9.04M Sell
155,668
-4,300
-3% -$265K 0.08% 215
2021
Q2 		$10.1M Sell
159,968
-42,950
-21% -$2.83M 0.09% 214
2021
Q1 		$12.9M Sell
202,918
-272,027
-57% -$15.8M 0.13% 198
2020
Q4 		$24.9M Sell
474,945
-125,969
-21% -$6.21M 0.27% 135
2020
Q3 		$26.3M Buy
600,914
+4,138
+0.7% +$183K 0.33% 102
2020
Q2 		$26.3M Buy
596,776
+90,449
+18% +$3.82M 0.36% 86
2020
Q1 		$19.7M Sell
506,327
-29,735
-6% -$1.52M 0.31% 100
2019
Q4 		$30.3M Buy
536,062
+61,237
+13% +$3.41M 0.35% 89
2019
Q3 		$25.3M Buy
474,825
+6,446
+1% +$346K 0.32% 94
2019
Q2 		$27.3M Sell
468,379
-4,971
-1% -$267K 0.36% 84
2019
Q1 		$23.5M Buy
473,350
+21,457
+5% +$945K 0.32% 90
2018
Q4 		$16.8M Sell
451,893
-133,039
-23% -$4.84M 0.27% 107
2018
Q3 		$22.1M Sell
584,932
-208,278
-26% -$8.67M 0.3% 102
2018
Q2 		$34.7M Sell
793,210
-1,728
-0.2% -$81.2K 0.51% 59
2018
Q1 		$40M Sell
794,938
-31,136
-4% -$1.83M 0.61% 46
2017
Q4 		$54.4M Buy
826,074
+10,363
+1% +$659K 0.8% 33
2017
Q3 		$48.8M Buy
815,711
+125,080
+18% +$7.44M 0.76% 33
2017
Q2 		$44.8M Buy
690,631
+233,929
+51% +$14.8M 0.72% 37
2017
Q1 		$28.5M Sell
456,702
-1,220
-0.3% -$73.4K 0.44% 76
2016
Q4 		$26.4M Sell
457,922
-1,180
-0.3% -$69.7K 0.42% 90
2016
Q3 		$27.3M Sell
459,102
-1,683
-0.4% -$103K 0.45% 82
2016
Q2 		$28.6M Sell
460,785
-3,100
-0.7% -$191K 0.49% 70
2016
Q1 		$28.6M Sell
463,885
-96,605
-17% -$5.69M 0.5% 66
2015
Q4 		$34.1M Sell
560,490
-8,115
-1% -$483K 0.63% 41
2015
Q3 		$28.8M Sell
568,605
-20,072
-3% -$1.07M 0.48% 66
2015
Q2 		$30.3M Sell
588,677
-97,846
-14% -$5.06M 0.46% 90
2015
Q1 		$34.9M Sell
686,523
-30,766
-4% -$1.59M 0.52% 76
2014
Q4 		$38.2M Sell
717,289
-29,255
-4% -$1.49M 0.57% 64
2014
Q3 		$34M Sell
746,544
-212,582
-22% -$10M 0.53% 73
2014
Q2 		$45.4M Sell
959,126
-7,826
-0.8% -$364K 0.66% 50
2014
Q1 		$44.5M Buy
966,952
+7,683
+0.8% +$356K 0.66% 53
2013
Q4 		$46.5M Buy
959,269
+46,316
+5% +$2.17M 0.68% 55
2013
Q3 		$39.6M Sell
912,953
-8,520
-0.9% -$364K 0.61% 62
2013
Q2 		$37.7M Buy
+921,473
New +$38.4M 0.61% 62

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Trust Walden's XRAY Position: Q4 2024 in Review

Boston Trust Walden sold out of Dentsply Sirona (XRAY) in Q4 2024, closing a stake of 10,650 shares — an estimated $288K sold.

Boston Trust Walden first reported a position in XRAY in Q2 2013 and held it in 46 quarters. The position peaked at $54.4M in Q4 2017. 360 funds tracked by Wall St. Rank hold XRAY as of Q4 2024.

  • Boston Trust Walden reported no remaining Dentsply Sirona position as of Q4 2024 after selling out during the quarter.
  • Boston Trust Walden sold 10,650 Dentsply Sirona shares in Q4 2024, an estimated $288K.
  • Boston Trust Walden first reported a position in Dentsply Sirona in Q2 2013 and held it in 46 quarters.
  • Boston Trust Walden's Dentsply Sirona position peaked at $54.4M in Q4 2017.
  • 360 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2024.

Based on Boston Trust Walden's 13F filing for Q4 2024, filed 24 Jan 2025.